ROSETTA INPHARMATICS INC
S-1/A, EX-27.1, 2000-06-21
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: ROSETTA INPHARMATICS INC, S-1/A, EX-23.3, 2000-06-21
Next: ZANY BRAINY INC, S-4/A, 2000-06-21



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   YEAR                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-2000
<PERIOD-START>                             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               DEC-31-1999             MAR-31-2000
<CASH>                                           8,312                  46,511
<SECURITIES>                                    10,951                   8,684
<RECEIVABLES>                                      156                      25
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                19,706                  56,175
<PP&E>                                           5,471                   6,121
<DEPRECIATION>                                   1,362                   1,705
<TOTAL-ASSETS>                                  34,788                  79,550
<CURRENT-LIABILITIES>                            4,255                   5,099
<BONDS>                                          1,389                   1,123
                                0                       0
                                         10                      15
<COMMON>                                             5                       7
<OTHER-SE>                                      25,821                  69,770
<TOTAL-LIABILITY-AND-EQUITY>                    34,788                  79,550
<SALES>                                              0                       0
<TOTAL-REVENUES>                                   983                     292
<CGS>                                                0                       0
<TOTAL-COSTS>                                   21,066                   8,670
<OTHER-EXPENSES>                                    82                      26
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                 293                      71
<INCOME-PRETAX>                               (19,820)                 (7,853)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                           (19,820)                 (7,853)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                  (19,820)                 (7,853)
<EPS-BASIC>                                     (4.92)                  (2.77)
<EPS-DILUTED>                                   (4.92)                  (2.77)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission